LEADER 00967nam0 2200277 450 001 000031855 005 20220316123831.0 010 $a978-88-7947-656-0 100 $a20180405d2017----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa-------001yy 200 1 $aMetodi & didattiche delle attivitą motorie$fDomenico Tafuri, Gaetano Raiola 210 $aNapoli$cIdelson-Gnocchi$dc2017 215 $a82 p.$cill.$d21 cm 500 10$aMetodi & didattiche delle attivitą motorie$91511267 610 1 $aAttivitą motorie$aAspetti psicologici 676 $a152.3$v22$9Psicologia fisiologica. Movimenti e funzioni motorie 700 1$aTafuri,$bDomenico$0633217 701 1$aRaiola,$bGaetano$0751802 801 0$aIT$bUNIPARTHENOPE$c20180405$gRICA$2UNIMARC 912 $a000031855 951 $a152-M/1$b46873$cNAVA1$d2018 951 $aPARTH-TAF/1$b46874$cNAVA1$d2018 996 $aMetodi & didattiche delle attivitą motorie$91511267 997 $aUNIPARTHENOPE LEADER 05273nam 2200625 450 001 9910830249403321 005 20230803203735.0 010 $a1-118-87003-4 010 $a1-118-86999-0 010 $a1-118-86988-5 035 $a(CKB)3710000000199290 035 $a(EBL)1744262 035 $a(SSID)ssj0001340560 035 $a(PQKBManifestationID)11770210 035 $a(PQKBTitleCode)TC0001340560 035 $a(PQKBWorkID)11380371 035 $a(PQKB)11512696 035 $a(OCoLC)889314286 035 $a(MiAaPQ)EBC1744262 035 $a(EXLCZ)993710000000199290 100 $a20140805h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aProgress in inorganic chemistry$hVolume 59 /$fedited by Kenneth D. Karlin 210 1$aHoboken, New Jersey :$cJohn Wiley & Sons, Inc.,$d2014. 210 4$d©2014 215 $a1 online resource (593 p.) 225 1 $aProgress in Inorganic Chemistry 300 $aDescription based upon print version of record. 311 $a1-118-87016-6 320 $aIncludes bibliographical references and indexes. 327 $aProgress in Inorganic Chemistry; Contents; Chapter 1: Iron Catalysis in Synthetic Chemistry; I. INTRODUCTION; II. ADDITION REACTIONS; A. Cycloadditions; 1. The [2+2] Cycloaddition; 2. The [3+2] Cycloaddition; 3. The [2+2+2] Cycloaddition; 4. The [4+2] Cycloaddition; B. Cyclopropanation; C. Aziridination and Aziridine Ring-Opening Reactions; D. Carbometalation of C-C Unsaturated Bond; E. Michael Addition; F. Barbier-Type Reaction; G. Kharasch Reaction; III. THE C-C BOND FORMATIONS VIA C-H FUNCTIONALIZATION; A. The C-H Arylation; 1. Direct Arylation With Organometallic Reagents 327 $a2. Direct Arylation With Aryl HalidesB. The C-C Bond Formation Via Cross-Dehydrogenative Coupling; 1. The CDC Between Two sp3 C-H Bonds; 2. The CDC Between sp3 and sp2 C-H Bonds; 3. The CDC Between sp3 and sp C-H Bonds; C. The C-C Bond Formation via Cross-Decarboxylative Coupling; D. The C-C Bond Formation via Alkene Insertion; E. Oxidative Coupling of Two C-H Bonds; IV. THE C-H BOND OXIDATION; A. Hydroxylation; B. Epoxidation; C. cis-Dihydroxylation; V. CROSS-COUPLING REACTIONS; A. Alkenyl Derivatives as Coupling Partners; B. Aryl Derivatives as Coupling Partners 327 $aC. Alkyl Derivatives as Coupling Partners1. Low-Valent Iron Complex in Cross-Coupling Reactions; D. Acyl Derivatives as Coupling Partners; E. Iron-Catalyzed C-O, C-S, and C-N Cross-Coupling Reaction; F. Iron-Catalyzed Mizoraki-Heck Reaction; G. Iron-Catalyzed Negishi Coupling Reaction; H. Suzuki-Miyaura Coupling Reaction; I. Sonogashira Reaction; J. Mechanism of Cross-Coupling Reactions; K. Hydrocarboxylation; L. Enyne Cross-Coupling Reaction; VI. DIRECT C-N BOND FORMATION VIA C-H OXIDATION; VII. IRON-CATALYZED AMINATION; A. Allylic Aminations; B. Intramolecular Allylic Amination 327 $aVIII. SULFOXIDATIONS AND SYNTHESIS OF SULFOXIMINES, SULFIMIDES, AND SULFOXIMIDESA. Sulfoxidation; B. Synthesis of Sulfoximines, Sulfimides, and Sulfoximides; 1. Mechanism; IX. REDUCTION REACTIONS; A. Hydrosilylation of Alkenes; B. Hydrosilylation of Aldehydes and Ketones; C. Hydrogenation of C-C Unsaturated Bonds; D. Hydrogenation of Ketones; E. Hydrogenation of Imines; F. Reduction of Nitroarene to Anilines; G. Hydrogenation of Carbon Dioxide and Bicarbonate; H. Amide Reduction; I. Reductive Aminations; X. TRIFLUOROMETHYLATION; XI. CONCLUSION; ACKNOWLEDGMENTS; ABBREVIATIONS; REFERENCES 327 $aChapter 2: A New Paradigm for Photodynamic Therapy Drug Design: Multifunctional, Supramolecular DNA Photomodification Agents Featuring Ru(II)/Os(II) Light Absorbers Coupled to Pt(II) or Rh(III) Bioactive SitesI. INTRODUCTION; A. Scope and Limitations; B. Cancer; C. Deoxyribonucleic Acid as a Target; II. PHOTODYNAMIC THERAPY; A. Requirements; B. Traditional PDT Agents; C. Ruthenium(II) Light Absorbers as PDT Agents; III. PLATINUM AND RHODIUM CENTERS AS BIOACTIVE SITES; A. Platinum(II) Based Chemotherapeutics; 1. Cisplatin; 2. Second and Third Generation Pt(II) Drugs 327 $aB. Rhodium as a Bioactive Site 330 $a This series provides inorganic chemists and materials scientists with a forum for critical, authoritative evaluations of advances in every area of the discipline. Volume 59 continues to report recent advances with a significant, up-to-date selection of contributions by internationally-recognized researchers. The chapters of this volume are devoted to the following topics: Iron Catalysis in Synthetic Chemistry A New Paradigm for Photodynamic Therapy Drug Design: Multifunctional, Supramolecular DNA Photomodification Agents Featuring Ru(II)/Os(II) Light Absorbers Coupled t 410 0$aProgress in Inorganic Chemistry 606 $aChemistry, Inorganic$xExperiments 606 $aChemistry, Inorganic$vLaboratory manuals 615 0$aChemistry, Inorganic$xExperiments. 615 0$aChemistry, Inorganic 676 $a546.851 702 $aKarlin$b Kenneth D. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830249403321 996 $aProgress in inorganic chemistry$9790883 997 $aUNINA